GlassScriptPhysician profile
Justin Schwarz
NPI 1063822112
$1,415.87
in general payments reported to CMS, 2019-2025
9 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $353 · 2023: $255 · 2024: $356 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $515.90 | 2021-2025 | Pipeline, Rist, Solitaire X |
| Depuy Synthes Sales INC. | $223.52 | 2022-2025 | Zero-P Va |
| Integra Lifesciences Corporation | $169.31 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Stryker Corporation | $154.56 | 2021-2025 | Surpass Evolve, Axs Vecta 71 |
| Gilead Sciences, INC. | $146.44 | 2021-2023 | |
| Microvention, INC. | $55.93 | 2025 | Web Aneurysm Embolization System |
| Phenox INC. | $55.34 | 2021 | |
| Nuvasive, INC. | $48.03 | 2023 | Propel |
| Penumbra, INC. | $46.84 | 2021-2023 | Penumbra Coil 400 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Schwarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.